Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
92.25
-2.10 (-2.23%)
Feb 21, 2025, 4:00 PM EST - Market closed
Blueprint Medicines Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$123.61
Upside
+33.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +35.50% | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $133 | Strong Buy | Reiterates | $133 | +44.17% | Feb 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +46.34% | Feb 14, 2025 |
| Needham | Needham | Strong Buy Reiterates $133 | Strong Buy | Reiterates | $133 | +44.17% | Feb 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $126 → $129 | Buy | Maintains | $126 → $129 | +39.84% | Feb 4, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $109 → $119 | Hold | Maintains | $109 → $119 | +29.00% | Jan 27, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +35.50% | Jan 15, 2025 |
| Wedbush | Wedbush | Buy Reiterates $135 → $124 | Buy | Reiterates | $135 → $124 | +34.42% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +46.34% | Jan 13, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $140 | Buy | Reiterates | $140 | +51.76% | Jan 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +46.34% | Dec 17, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 11, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +35.50% | Dec 9, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $125 | Buy | Reiterates | $125 | +35.50% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +46.34% | Nov 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | +46.34% | Nov 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.